Talsig 20

About

Talsig 20 contains Telmisartan, an angiotensin II receptor blocker (ARB). This medication works by selectively blocking the binding of angiotensin II to its AT1 receptors, which are found in various tissues, including vascular smooth muscle and the adrenal gland. By blocking these receptors, Telmisartan prevents the vasoconstrictive and aldosterone-secreting effects of angiotensin II, leading to vasodilation and a reduction in blood pressure. It is primarily used for the treatment of essential hypertension and for cardiovascular risk reduction in high-risk individuals.

Its long duration of action allows for once-daily dosing, providing consistent blood pressure control throughout a 24-hour period. Telmisartan is also noted for its favorable metabolic profile and is often considered for patients with co-existing conditions such as diabetes. Regular monitoring of blood pressure, electrolytes, and kidney function is important during therapy.

Uses

• Treatment of essential hypertension (high blood pressure)
• Reduction of cardiovascular morbidity and mortality
• Prevention of stroke and myocardial infarction
• Management of diabetic nephropathy in type 2 diabetes

Directions For Use

Take orally once daily, with or without food. Adhere strictly to your physician's dosage recommendations.

Benefits

• Effective in lowering high blood pressure
• Reduces risk of major cardiovascular events
• Provides 24-hour blood pressure control
• Well-tolerated with a low incidence of cough
• Helps protect kidney function in certain patients
• Suitable for long-term management of hypertension

Side Effects

• Dizziness
• Headache
• Fatigue
• Hypotension (low blood pressure)
• Nausea
• Diarrhea
• Back pain
• Upper respiratory tract infection
• Cough (less common than ACE inhibitors)
• Hyperkalemia (high potassium levels)
• Syncope (fainting)
• Angioedema (rare, severe allergic reaction)

Safety Measures

• Alcohol - Alcohol can increase the hypotensive effect of Telmisartan, potentially causing dizziness or lightheadedness. Avoid excessive consumption.
• Pregnancy - Contraindicated during the second and third trimesters due to significant risk of fetal injury or death. Discontinue immediately if pregnancy is detected.
• Breastfeeding - Not recommended during breastfeeding as Telmisartan may be excreted in breast milk and pose risks to the infant. Consult a healthcare professional.
• Liver - Use with caution in patients with severe hepatic impairment as Telmisartan is primarily eliminated via bile. Dosage adjustment may be necessary.
• Kidney - Use with caution in patients with renal impairment, especially those with renal artery stenosis. Monitor kidney function regularly.
• Lung - Generally considered safe for patients with lung conditions. It is less likely to cause cough compared to ACE inhibitors.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.